Comment by
Chuckie18 on Mar 10, 2021 12:34am
1 Wall Street analysts have issued ratings and price targets for FSD Pharma in the last 12 months. Their average twelve-month price target is $11.00, predicting that the stock has a possible upside of 397.74%. The high price target for HUGE is $11.00 and the low price target for HUGE is $11.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Comment by
Chuckie18 on Mar 10, 2021 12:35am
Leopards can't change their spots, have to skin the leopard. With the recent departure of management member it's a start, but theirs still more skinning to do. Junk company, junk management. Junk management. The company has changed strategy and has changed management time. It is necessary to eradicate the cancer.
Comment by
Chuckie18 on Mar 10, 2021 12:36am
Shorts are really working to keep this from printing $2.29. As soon as it prints, shorts will cover and pro scanners will pick it up and give this a nice pop! NASDAQ going for HOD! Don't chase...get on the $HUGE bus before $2.29! GLTA!